0 likes | 17 Views
The global non-coding RNA assays market is anticipated to attain a robust CAGR of 14% over the forecast period, i.e., 2023 u2013 2035. The market is segmented on the basis of end-user into laboratories, research centers, and others, out of which, the research centers segment is anticipated to hold the noteworthy share in the market over the forecast period, owing to the increasing prevalence of genetic diseases, along with rising demand for research and development activities for novel drugs.<br><br>For More Information: https://www.researchnester.com/reports/non-coding-rna-assays-market/3730<br>
E N D